Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Leishmaniasis, Cutaneous/drug therapy/parasitology"'
Autor:
Jorge Arevalo, Marleen Boelaert, Roger V. Araujo-Castillo, Jean-Claude Dujardin, Gianfranco Tulliano, Marcela Lazo, Jo Robays, Giovanna Santamaria-Castrellon, François Chappuis, Alejandro Llanos-Cuentas, Simonne De Doncker, Luis Eduardo Ramirez, Cesar Miranda-Verastegui
Publikováno v:
Clinical Infectious Diseases, Vol. 46, No 2 (2008) pp. 223-31
BACKGROUND: Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy is hampered by cumbersome administration, toxicity, and potential failure. Knowledge of factors influencing treatment outcome is essential for success
Publikováno v:
Planta Medica
Planta Medica, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩
Planta Medica, Georg Thieme Verlag, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩
Planta Medica, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩
Planta Medica, Georg Thieme Verlag, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩
International audience; Seven benzo[c]phenanthridines, synthetic or isolated from Zanthoxylum rhoifolium root bark, were evaluated against Leishmania amazonensis axenic amastigotes. Five of them were considered leishmanicidal, with IC50 values rangin